⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for idhr132 mutations

Every month we try and update this database with for idhr132 mutations cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsNCT02381886
Advanced Malign...
IDH305
18 Years - Novartis
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsNCT02381886
Advanced Malign...
IDH305
18 Years - Novartis
Trial of IDH305 in IDH1 Mutant Grade II or III GliomaNCT02977689
Glioma
IDH305
18 Years - NYU Langone Health
Trial of IDH305 in IDH1 Mutant Grade II or III GliomaNCT02977689
Glioma
IDH305
18 Years - NYU Langone Health
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: